On the 9th, Organoid Science, which newly listed on the KOSDAQ market, is showing strength in the early trading.
As of 9:14 a.m. on this day, Organoid Science is trading at 29,300 won, up 8,300 won (39.52%) from the public offering price. Newly listed stocks can rise by up to 400% beyond the 30% limit on the first day.
Organoid Science, a regenerative medicine corporation, has technology that recreates human organs using stem cells cultured in three dimensions (3D), specifically organoids (mini organs). Major products include the regenerative treatment 'ATORM' and the new material efficacy evaluation solution 'ODISEI.'
Organoid Science conducted demand forecasting for institutional investors from the 16th to the 22nd of last month, and the public offering price was set at the upper end of the desired band (17,000 won to 21,000 won) at 21,000 won. The competition ratio for institutional subscriptions was 1,066.9 to 1, while the competition ratio for general investors in the public offering was 858.1 to 1.